Rapid Therapeutic Science Laboratories, Inc. (RTSL)
USD 0.0
(2.56%)
USD 0.0
(2.56%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2022 | -1.23 Million USD | 41.39% |
| 2021 | -2.11 Million USD | 0.0% |
| 2019 | -169.69 Thousand USD | 0.0% |
| 2017 | -135.68 Thousand USD | -527.69% |
| 2016 | -21.61 Thousand USD | -79.83% |
| 2015 | -12.02 Thousand USD | 2.3% |
| 2014 | -12.3 Thousand USD | 35.1% |
| 2013 | -18.95 Thousand USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 Q2 | 27.3 Thousand USD | 129.58% |
| 2023 Q1 | -92.3 Thousand USD | -203.21% |
| 2022 Q1 | -762.14 Thousand USD | -28.12% |
| 2022 Q2 | -101.12 Thousand USD | 86.73% |
| 2022 Q4 | -30.44 Thousand USD | 91.19% |
| 2022 Q3 | -345.65 Thousand USD | -241.81% |
| 2022 FY | - USD | 41.39% |
| 2021 Q2 | -527.05 Thousand USD | -5.01% |
| 2021 Q3 | -490.6 Thousand USD | 6.92% |
| 2021 FY | - USD | 0.0% |
| 2021 Q1 | -501.92 Thousand USD | 0.0% |
| 2021 Q4 | -594.85 Thousand USD | -21.25% |
| 2020 Q2 | -518.77 Thousand USD | -133.42% |
| 2020 Q3 | -596.32 Thousand USD | -14.95% |
| 2020 Q1 | -222.25 Thousand USD | -71.8% |
| 2019 Q4 | -129.36 Thousand USD | -518.8% |
| 2019 Q2 | -22.97 Thousand USD | -17.72% |
| 2019 Q1 | -19.51 Thousand USD | 42.65% |
| 2019 Q3 | -20.9 Thousand USD | 9.0% |
| 2019 FY | - USD | 0.0% |
| 2018 Q4 | -34.02 Thousand USD | -39.44% |
| 2018 Q3 | -24.4 Thousand USD | 73.4% |
| 2018 Q2 | -91.74 Thousand USD | 96.34% |
| 2018 Q1 | -2.5 Million USD | -46345.49% |
| 2017 Q4 | -5399.00 USD | -74.39% |
| 2017 Q1 | -8770.00 USD | -213.21% |
| 2017 Q2 | -8218.00 USD | 6.29% |
| 2017 FY | - USD | -527.69% |
| 2017 Q3 | -3096.00 USD | 62.33% |
| 2016 Q3 | -3365.00 USD | 49.63% |
| 2016 Q4 | -2800.00 USD | 16.79% |
| 2016 FY | - USD | -79.83% |
| 2016 Q1 | -3552.00 USD | -7.64% |
| 2016 Q2 | -6681.00 USD | -88.09% |
| 2015 Q4 | -3300.00 USD | -106.9% |
| 2015 Q1 | -1500.00 USD | 0.0% |
| 2015 Q2 | -3573.00 USD | -138.2% |
| 2015 FY | - USD | 2.3% |
| 2015 Q3 | -1595.00 USD | 55.36% |
| 2014 Q4 | -1500.00 USD | 1.96% |
| 2014 Q3 | -1530.00 USD | 80.32% |
| 2014 FY | - USD | 35.1% |
| 2014 Q2 | -7773.00 USD | -34.85% |
| 2014 Q1 | -5764.00 USD | -16.44% |
| 2013 Q4 | -4950.00 USD | -10.74% |
| 2013 Q2 | -3773.00 USD | 0.0% |
| 2013 FY | - USD | 0.0% |
| 2013 Q3 | -4470.00 USD | -18.47% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| CVR Medical Corp. | - USD | Infinity% |
| BioElectronics Corporation | -274.29 Thousand USD | -351.843% |
| IR-Med Inc. | -4.89 Million USD | 74.666% |
| Polarean Imaging plc | -11.19 Million USD | 88.929% |
| Medical Supply International USA, Inc. | 456.06 Thousand USD | 371.754% |
| Avitar, Inc. | -1.66 Million USD | 25.689% |
| AVITA Medical, Inc. | -39.56 Million USD | 96.868% |
| Manhattan Scientifics, Inc. | -1.16 Million USD | -6.474% |
| Össur hf. | 137.38 Million USD | 100.902% |
| Zecotek Photonics Inc. | -3.44 Million USD | 63.995% |
| QHSLab, Inc. | -91.29 Thousand USD | -1257.564% |
| Wellstar International, Inc. | -1.35 Million USD | 8.637% |
| Össur hf. | 137.38 Million USD | 100.902% |
| Bionovate Technologies Corp | - USD | Infinity% |
| EKF Diagnostics Holdings plc | 9.77 Million USD | 112.68% |
| Escalon Medical Corp. | -58.46 Thousand USD | -2019.979% |
| Aurora Spine Corporation | -454.37 Thousand USD | -172.76% |
| BrainsWay Ltd. | -2.31 Million USD | 46.371% |
| Lattice Biologics Ltd. | - USD | Infinity% |
| NewCardio, Inc. | -9.37 Million USD | 86.786% |
| Hamilton Thorne Ltd. | 5.52 Million USD | 122.446% |
| Vivos Inc. | -2.79 Million USD | 55.628% |
| MicroPort Scientific Corporation | -347.57 Million USD | 99.643% |
| Kelyniam Global, Inc. | -197.69 Thousand USD | -526.918% |
| REMSleep Holdings, Inc. | -1.66 Million USD | 25.722% |
| CYduct Diagnostics, Inc. | -378.9 Thousand USD | -227.089% |
| Nanomix Corporation | -8.13 Million USD | 84.774% |
| Theraclion SA | -2.05 Million USD | 39.567% |
| Lifeline Biotechnologies, Inc. | - USD | Infinity% |
| Wellness Center USA, Inc. | -707.03 Thousand USD | -75.291% |
| Positron Corporation | -1.45 Million USD | 14.653% |
| Rafina Innovations Inc. | - USD | Infinity% |
| Electromedical Technologies, Inc. | -1.72 Million USD | 28.023% |
| Lombard Medical, Inc. | -28.06 Million USD | 95.584% |
| ALR Technologies Inc. | -6.4 Million USD | 80.636% |
| Stratec SE | 39.91 Million USD | 103.105% |
| Vycor Medical, Inc. | 100.94 Thousand USD | 1327.783% |
| Heart Tronics, Inc. | -14.85 Million USD | 91.658% |
| Nu-Med Plus, Inc. | -118.25 Thousand USD | -948.006% |
| Perimeter Medical Imaging AI, Inc. | -13.27 Million USD | 90.665% |
| SANUWAVE Health, Inc. | -9.15 Million USD | 86.458% |
| VMS Rehab Systems, Inc. | -68.55 USD | -1807866.448% |
| Guided Therapeutics, Inc. | -3.12 Million USD | 60.353% |
| Ingen Technologies, Inc. | -8639.00 USD | -14246.116% |
| Odyssey Group International, Inc. | -2.13 Million USD | 42.034% |
| United American Healthcare Corporation | -59 Thousand USD | -2000.612% |
| ECGI Holdings, Inc. | -2.99 Million USD | 58.556% |
| Capital Group Holdings, Inc. | -629.18 Thousand USD | -96.979% |
| ADM Tronics Unlimited, Inc. | -514.02 Thousand USD | -141.109% |
| Urologix, Inc. | -6.34 Million USD | 80.464% |
| Nexeon MedSystems Inc. | -765.96 Thousand USD | -61.803% |
| SS Innovations International, Inc. | -20.37 Million USD | 93.918% |
| Qualis Innovations, Inc. | -222.81 Thousand USD | -456.221% |
| Smith & Nephew plc | 1 Billion USD | 100.124% |
| NIOX Group Plc | 11.07 Million USD | 111.191% |
| Fuse Medical, Inc. | 1.83 Million USD | 167.528% |
| Broncus Holding Corporation | -25.19 Million USD | 95.082% |
| Brain Scientific Inc. | -7.93 Million USD | 84.379% |
| Pressure BioSciences, Inc. | -9.39 Million USD | 86.803% |
| Health Logic Interactive Inc. | -18.4 Thousand USD | -6635.658% |